Randomized controlled trial of lobaplatin plus etoposide vs. cisplatin plus etoposide as first-line therapy in patients with extensive-stage small cell lung cancer

The majority of previous studies of lobaplatin in small cell lung cancer (SCLC) are small phase I–II studies. The present study aimed to verify the non-inferiority (in terms of efficacy) of lobaplatin plus etoposide (EL) vs. cisplatin plus etoposide (EP) in patients with previously untreated extensi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncol Lett
Main Authors: Cheng, Ying, Fan, Yun, Liu, Xiaoqing, Liu, Yunpeng, Liu, Jiwei, Wang, Dong, Yu, Yan, Qin, Shukui, Liu, Wei, Huang, Cheng, Zhang, Helong, Liang, Jun, Shi, Jianhua, Sheng, Lijun, Yu, Hao
Formato: Artigo
Idioma:Inglês
Publicado: D.A. Spandidos 2019
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6447897/
https://ncbi.nlm.nih.gov/pubmed/30988825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2019.10125
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares